PureTech Health (PRTC)
(Delayed Data from NSDQ)
$28.68 USD
+0.17 (0.60%)
Updated May 16, 2024 12:04 PM ET
After-Market: $29.25 +0.57 (1.98%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Balance Sheet
Fiscal Year End for PureTech Health PLC Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 327 | 350 | 481 | 404 | 162 |
Receivables | 14 | 22 | 8 | 3 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 14 | 13 | 8 | 4 |
Total Current Assets | 347 | 386 | 502 | 414 | 169 |
Net Property & Equipment | 10 | 23 | 27 | 23 | 21 |
Investments & Advances | 326 | 278 | 397 | 530 | 726 |
Other Non-Current Assets | 0 | 1 | 1 | 2 | 2 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1 | 1 | 1 | 1 | 1 |
Deposits & Other Assets | 1 | 0 | 1 | 0 | 0 |
Total Assets | 694 | 703 | 946 | 990 | 941 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 4 | 2 | 4 | 26 | 1 |
Accounts Payable | 44 | 55 | 36 | 22 | 20 |
Current Portion Long-Term Debt | 0 | 5 | 1 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 30 | 182 | 129 | 115 |
Total Current Liabilities | 51 | 97 | 226 | 181 | 139 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 52 | 20 | 90 | 109 | 117 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 10 | 14 | 15 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 114 | 4 | 3 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 236 | 155 | 362 | 336 | 291 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 5 | 5 | 5 | 5 | 5 |
Capital Surplus | 290 | 290 | 289 | 289 | 288 |
Retained Earnings | 84 | 150 | 200 | 260 | 254 |
Other Equity | 123 | 129 | 90 | 99 | 103 |
Treasury Stock | 45 | 26 | 0 | 0 | 0 |
Total Shareholder's Equity | 458 | 548 | 584 | 654 | 650 |
Total Liabilities & Shareholder's Equity | 694 | 703 | 946 | 990 | 941 |
Total Common Equity | 458 | 548 | 584 | 654 | 650 |
Shares Outstanding | 27.00 | 27.80 | 28.70 | 28.50 | NA |
Book Value Per Share | 16.97 | 19.70 | 20.35 | 22.93 | -0.01 |
Fiscal Year End for PureTech Health PLC Sponsored ADR falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 327 | -99,999 | -99,648 | -99,999 |
Receivables | NA | 14 | NA | 2 | NA |
Notes Receivable | NA | 0 | NA | NA | NA |
Inventories | NA | 0 | NA | NA | NA |
Other Current Assets | NA | 6 | NA | 7 | NA |
Total Current Assets | NA | 347 | NA | 360 | NA |
Net Property & Equipment | NA | 10 | NA | 11 | NA |
Investments & Advances | NA | 326 | NA | 310 | NA |
Other Non-Current Assets | NA | 0 | NA | 0 | NA |
Deferred Charges | NA | 0 | NA | NA | NA |
Intangibles | NA | 1 | NA | 1 | NA |
Deposits & Other Assets | NA | 1 | NA | 1 | NA |
Total Assets | NA | 694 | NA | 694 | NA |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 4 | NA | 2 | NA |
Accounts Payable | NA | 44 | NA | 31 | NA |
Current Portion Long-Term Debt | NA | 0 | NA | NA | NA |
Current Portion Capital Leases | NA | 0 | NA | NA | NA |
Accrued Expenses | NA | 0 | NA | NA | NA |
Income Taxes Payable | NA | 0 | NA | 12 | NA |
Other Current Liabilities | NA | 0 | NA | 0 | NA |
Total Current Liabilities | NA | 51 | NA | 49 | NA |
Mortgages | NA | 0 | NA | NA | NA |
Deferred Taxes/Income | NA | 52 | NA | 9 | NA |
Convertible Debt | NA | 0 | NA | NA | NA |
Long-Term Debt | NA | 0 | NA | NA | NA |
Non-Current Capital Leases | NA | 0 | NA | NA | NA |
Other Non-Current Liabilities | NA | NA | 106 | NA | |
Minority Interest (Liabilities) | NA | 0 | NA | NA | NA |
Total Liabilities | NA | 236 | NA | 185 | NA |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | NA | NA | NA |
Common Stock (Par) | NA | 5 | NA | 5 | NA |
Capital Surplus | NA | 290 | NA | 290 | NA |
Retained Earnings | NA | 84 | NA | 125 | NA |
Other Equity | NA | 123 | NA | 122 | NA |
Treasury Stock | NA | 45 | NA | 33 | NA |
Total Shareholder's Equity | NA | 458 | NA | 509 | NA |
Total Liabilities & Shareholder's Equity | NA | 694 | NA | 694 | NA |
Total Common Equity | 0 | 458 | 0 | 100,508 | 0 |
Shares Outstanding | 27.00 | 27.00 | 27.30 | 27.60 | 27.80 |
Book Value Per Share | 0.00 | 16.97 | 0.00 | 3,641.59 | 0.00 |